Reduced Dose of Prophylactic Dexamethasone for Elderly Patients Receiving Moderate Emetogenic Chemotherapy
Status:
Completed
Trial end date:
2020-01-01
Target enrollment:
Participant gender:
Summary
Feasibility study to evaluate the efficacy of reduced prophylactic dose of dexamethasone in
elderly patients receiving moderate emetogenic chemotherapy